IBDEI144 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19855,2)
 ;;=^24401
 ;;^UTILITY(U,$J,358.3,19856,0)
 ;;=394.9^^112^1192^14
 ;;^UTILITY(U,$J,358.3,19856,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19856,1,3,0)
 ;;=3^394.9
 ;;^UTILITY(U,$J,358.3,19856,1,4,0)
 ;;=4^MITRAL VALVE DISEASE
 ;;^UTILITY(U,$J,358.3,19856,2)
 ;;=^269571
 ;;^UTILITY(U,$J,358.3,19857,0)
 ;;=443.9^^112^1192^15
 ;;^UTILITY(U,$J,358.3,19857,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19857,1,3,0)
 ;;=3^443.9
 ;;^UTILITY(U,$J,358.3,19857,1,4,0)
 ;;=4^PERIPH VASCULAR DIS
 ;;^UTILITY(U,$J,358.3,19857,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,19858,0)
 ;;=424.1^^112^1192^3
 ;;^UTILITY(U,$J,358.3,19858,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19858,1,3,0)
 ;;=3^424.1
 ;;^UTILITY(U,$J,358.3,19858,1,4,0)
 ;;=4^AORTIC VALVE DIS
 ;;^UTILITY(U,$J,358.3,19858,2)
 ;;=^9330
 ;;^UTILITY(U,$J,358.3,19859,0)
 ;;=459.81^^112^1192^16
 ;;^UTILITY(U,$J,358.3,19859,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19859,1,3,0)
 ;;=3^459.81
 ;;^UTILITY(U,$J,358.3,19859,1,4,0)
 ;;=4^VENOUS INSUFFICIENCY
 ;;^UTILITY(U,$J,358.3,19859,2)
 ;;=^125826
 ;;^UTILITY(U,$J,358.3,19860,0)
 ;;=411.1^^112^1192^2
 ;;^UTILITY(U,$J,358.3,19860,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19860,1,3,0)
 ;;=3^411.1
 ;;^UTILITY(U,$J,358.3,19860,1,4,0)
 ;;=4^ANGINA PECTORIS/UNSTABLE
 ;;^UTILITY(U,$J,358.3,19860,2)
 ;;=^7455
 ;;^UTILITY(U,$J,358.3,19861,0)
 ;;=429.2^^112^1192^4
 ;;^UTILITY(U,$J,358.3,19861,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19861,1,3,0)
 ;;=3^429.2
 ;;^UTILITY(U,$J,358.3,19861,1,4,0)
 ;;=4^ASCVD
 ;;^UTILITY(U,$J,358.3,19861,2)
 ;;=^19738
 ;;^UTILITY(U,$J,358.3,19862,0)
 ;;=414.01^^112^1192^6
 ;;^UTILITY(U,$J,358.3,19862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19862,1,3,0)
 ;;=3^414.01
 ;;^UTILITY(U,$J,358.3,19862,1,4,0)
 ;;=4^CAD
 ;;^UTILITY(U,$J,358.3,19862,2)
 ;;=^303281
 ;;^UTILITY(U,$J,358.3,19863,0)
 ;;=401.9^^112^1192^10
 ;;^UTILITY(U,$J,358.3,19863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19863,1,3,0)
 ;;=3^401.9
 ;;^UTILITY(U,$J,358.3,19863,1,4,0)
 ;;=4^HYPERTENSION, ESSENTIAL
 ;;^UTILITY(U,$J,358.3,19863,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,19864,0)
 ;;=394.0^^112^1192^13
 ;;^UTILITY(U,$J,358.3,19864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19864,1,3,0)
 ;;=3^394.0
 ;;^UTILITY(U,$J,358.3,19864,1,4,0)
 ;;=4^MITRAL STENOSIS
 ;;^UTILITY(U,$J,358.3,19864,2)
 ;;=^78404
 ;;^UTILITY(U,$J,358.3,19865,0)
 ;;=796.3^^112^1192^12
 ;;^UTILITY(U,$J,358.3,19865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19865,1,3,0)
 ;;=3^796.3
 ;;^UTILITY(U,$J,358.3,19865,1,4,0)
 ;;=4^LOW BLOOD PRESSURE READING
 ;;^UTILITY(U,$J,358.3,19865,2)
 ;;=^273465
 ;;^UTILITY(U,$J,358.3,19866,0)
 ;;=796.2^^112^1192^9
 ;;^UTILITY(U,$J,358.3,19866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19866,1,3,0)
 ;;=3^796.2
 ;;^UTILITY(U,$J,358.3,19866,1,4,0)
 ;;=4^ELEVATED B/P w/o HTN
 ;;^UTILITY(U,$J,358.3,19866,2)
 ;;=^273464
 ;;^UTILITY(U,$J,358.3,19867,0)
 ;;=285.9^^112^1193^1
 ;;^UTILITY(U,$J,358.3,19867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19867,1,3,0)
 ;;=3^285.9
 ;;^UTILITY(U,$J,358.3,19867,1,4,0)
 ;;=4^ANEMIA
 ;;^UTILITY(U,$J,358.3,19867,2)
 ;;=^7007
 ;;^UTILITY(U,$J,358.3,19868,0)
 ;;=266.2^^112^1193^3
 ;;^UTILITY(U,$J,358.3,19868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19868,1,3,0)
 ;;=3^266.2
 ;;^UTILITY(U,$J,358.3,19868,1,4,0)
 ;;=4^B12 & FOLATE ANEMIA
 ;;^UTILITY(U,$J,358.3,19868,2)
 ;;=^87347
 ;;^UTILITY(U,$J,358.3,19869,0)
 ;;=272.0^^112^1193^4
 ;;^UTILITY(U,$J,358.3,19869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19869,1,3,0)
 ;;=3^272.0
 ;;^UTILITY(U,$J,358.3,19869,1,4,0)
 ;;=4^CHOLESTEROL (HYPER)
